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Abstract Previously we found that terfenadine, an H1
histamine receptor antagonist, acts as a potent apoptosis
inducer in melanoma cells through modulation of Ca
2?
homeostasis. In this report, focusing our attention on the
apoptotic mechanisms activated by terfenadine, we show
that this drug can potentially activate distinct intrinsic
signaling pathways depending on culture conditions.
Serum-deprived conditions enhance the cytotoxic effect of
terfenadine and caspase-4 and -2 are activated upstream of
caspase-9. Moreover, although we found an increase in
ROS levels, the apoptosis was ROS independent. Con-
versely, terfenadine treatment in complete medium induced
ROS-dependent apoptosis. Caspase-4, -2, and -9 were
simultaneously activated and p73 and Noxa induction were
involved. ROS inhibition prevented p73 and Noxa
expression but not p53 and p21 expression, suggesting a
role for Noxa in p53-independent apoptosis in melanoma
cells. Finally, we found that terfenadine induced autoph-
agy, that can promote apoptosis. These ﬁndings
demonstrate the great potential of terfenadine to kill mel-
anoma cells through different cellular signaling pathways
and could contribute to deﬁne new therapeutic strategies in
melanoma.
Keywords Terfenadine   Apoptosis   Autophagy   ROS  
Human melanoma
Introduction
Histamine is a biogenic amine that mediates numerous
physiological and pathological processes through the acti-
vation of speciﬁc histamine receptors (H1, H2, H3, and H4)
[1]. Although many in vitro and in vivo studies on the
modulatory roles of histamine in tumor development and
metastasis have been reported, the effect of histamine in
the progression of some types of tumors remains contro-
versial. In this respect, we have previously found that
histamine stimulates melanoma cell growth and that H1
histamine receptor antagonists induce apoptosis in a variety
of human melanoma cell lines [2, 3]. Other reports also
prove the antitumoral activity of H1 histamine receptor
antagonists in human leukemia, myeloma [4, 5], colon, and
liver cancer cells [6].
In one exploration of the molecular pathways involved
in the apoptosis induced by H1 antihistaminics, A375 cells
were treated with terfenadine (TEF), a highly potent H1
histamine receptor antagonist [7]. We found that TEF
induces DNA damage and caspase-2-dependent apoptosis
[2]. Moreover, these effects are the consequence of a
cytosolic Ca
2? increase induced by TEF treatment in a
dose-dependent manner [3].
The endoplasmic reticulum (ER) is one of the most
important intracellular Ca
2? storage organelles [8]. It has
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2? plays a vital executioner role in
the regulation of apoptosis. If the Ca
2? concentration in the
cytoplasm increases, there is a resultant increase in nuclear
Ca
2?. In the nucleus, Ca
2? modulates nucleases involved
in apoptosis [9]. Ca
2? also regulates another family of
proteins involved in the control of apoptosis, the calpains.
Calpains have been implicated in activation of ER-local-
ized caspase-4 in human cells [10]. Ca
2? release from ER
can also activate apoptosis through a mitochondrial-
dependent pathway. ER Ca
2? release triggers rapid accu-
mulation of Ca
2? by mitochondria and mitochondrial
membrane permeabilization [11, 12], resulting in the
release of pro-apoptotic factors from mitochondria such as
cytochrome c and caspase-9 activation [13]. Moreover, the
accumulation of Ca
2? in the mitochondrial matrix can
stimulate oxidative phosphorylation and enhance reactive
oxygen species (ROS) generation. Oxidative stress mark-
edly sensitizes mitochondria toward mitochondrial mem-
brane permeabilization induction and can also cause
damage to nucleic acids and proteins [14].
In response to DNA damage, p53 becomes stabilized by
phosphorylation and induces cell-cycle arrest through the
accumulation of the cyclin-dependent kinase inhibitor p21.
If p53 accumulates above a particular threshold, it can
induce apoptosis by induction of pro-apoptotic members of
the Bcl-2 family [15]. In addition, it has been found that
cells can trigger p53-independent DNA-damage-induced
apoptosis through transcriptional upregulation of the p53
homolog p73. p73-induced apoptosis is mediated by
induction of Bax, Puma, and Noxa [16].
Multiple stress signals, such as ROS and rapid increases
in intracellular Ca
2?, can trigger both apoptosis and mac-
roautophagy. In physiological conditions, macroautophagy
(referred to here as autophagy) is the major pathway that
eukaryotic cells use to degrade and recycle long-lived
proteins and aging cytoplasmic components. However, in
the presence of an apoptotic stimulus, autophagy has been
described as both an alternative route to cell death (termed
autophagic or type II cell death) and an adaptation mech-
anism to environmental stress. Moreover, autophagy and
apoptosis are cross-linked at multiple levels, although
their functional interrelationship is still being worked out
[17–20].
In the present work, we have observed that the presence
of serum in the medium of treatment decreases the intensity
of the death stimulus produced by TEF on A375 melanoma
cells. Thus, we have postulated that the environmental
conditions in which cells receive TEF treatment may
inﬂuence engagement of apoptotic mechanisms. The major
aims of this study were to identify the apoptotic pathways
activated by TEF and to analyze ROS involvement in TEF-
induced apoptosis and autophagy on melanoma cells in
different culture conditions.
Materials and methods
Chemicals and reagents
TEF, a-tocopherol (vitamin E), cyclic piﬁthrin-alpha,
BAPTA-AM and 3-methyladenine were purchased from
Sigma-Aldrich Quimica, S.A. (Madrid, Spain). Caspase-2
inhibitor was from Calbiochem (Darmstadt, Germany).
Caspase-4 and caspase-9 inhibitors were from PromoCell
GmbH (Heidelberg, Germany).
Acrylamide and bis-acrylamide solutions and Precision
Plus Protein Standards were obtained from Bio-Rad Lab-
oratories (Hercules, CA, USA). Bicinchoninic acid solution
and electrophoresis reagents were all obtained from Sigma-
Aldrich Quimica, S.A. (Madrid, Spain).
Polyclonal rabbit anti-cleaved caspase-3 antibody and
Atg7 rabbit monoclonal antibody were obtained from
Cell Signaling Technology (Danvers, MA, USA). Mouse
monoclonal to histone H2A.X (phospho S139), mouse
monoclonal antibody anti-p21, mouse monoclonal anti-
body anti-Noxa, and rabbit polyclonal antibody to LC3B
were from Abcam (Cambridge, UK). Mouse monoclonal
antibody PhosphoDetect
TM
anti-ATM (pSer
1981), rabbit
polyclonal antibody PhosphoDetect
TM
anti-p53 (pSer
15),
and mouse monoclonal antibody anti-p73 were obtained
from Calbiochem (Darmstadt, Germany). A mouse anti-
cytochrome c antibody was purchased from BD Pharm-
ingen (San Diego, CA, USA) and the anti-actin antibody
was from Sigma-Aldrich Co. (St Louis, MO, USA).
HRP-F(ab’)2 goat anti-mouse IgG (H ? L) and HRP-
F(ab’)2 goat anti-rabbit IgG (H ? L) secondary antibod-
ies were from Zymed Laboratories (South San Francisco,
CA, USA), and Alexa Fluor
 goat anti-rabbit and
Alexa Fluor
 goat anti-mouse secondary antibodies were
from Molecular Probes (Europe BV, Leiden, The
Netherlands).
Cell culture
Human melanoma cell lines A375, HT144 and Hs294T
(obtained from American Type Culture Collection, Rock-
ville, MD, USA) were routinely cultured in 75 cm
2 ﬂasks
and grown in a monolayer in Dulbecco’s Modiﬁed Eagle’s
Medium (Sigma-Aldrich Quimica, S.A., Madrid, Spain),
supplemented with 10% (v/v) heat-inactivated FCS
(Biochrom AG, Berlin, Germany), 2 mM L-glutamine and
antibiotic solution (100 lgm l
-1 streptomycin and
100 IU ml
-1 penicillin) (Sigma-Aldrich Quimica, S.A.,
Madrid, Spain) at 37C in a 5% CO2–95% air–water sat-
urated atmosphere. Trypsinization was performed at har-
vesting. The cell lines were examined during culture with
an inverted microscope (Olympus CK-2, Olympus,
Melville, NY, USA). Cells in the exponential phase of
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123growth were used in the experiments. Stock solutions of
TEF (50 mM) were prepared in dimethyl sulfoxide (Sigma-
Aldrich Quimica, S.A., Madrid, Spain). The ﬁnal treatment
concentration of dimethyl sulfoxide was not[0.05% (v/v)
dimethyl sulfoxide/culture medium. Control groups were
either untreated or treated with the corresponding doses of
dimethyl sulfoxide alone.
Cell viability assay
Cells were seeded into ﬂat-bottomed 96-well microtiter
plates at a density of 1 9 10
5 cells ml
-1 and allowed to
attach to the wells overnight. Subsequently, cells were
treated, and controls without treatment were also included
in each experiment. Cell viability was determined by
means of a colorimetric XTT viability assay kit (Roche
Molecular Biochemicals, Indianapolis, IN, USA) in
accordance with the instructions of the supplier. Absor-
bance at 490 nm was measured using a microplate reader
(ELx800, Bio-Tek Instruments, Winooski, VT), and cell
viability was calculated in relation to untreated control
cells as follows: (experimental absorbance/untreated con-
trol absorbance) 9 100. Twelve replicate wells were
analyzed for each test, and each assay was repeated 3–4
times.
Nuclear staining and immunoﬂuorescence
Melanoma cells were seeded at a density of 1 9 10
5
cells ml
-1 overnight on sterile glass coverslips in 24-well
plates before being treated. Treated and untreated cells on
the coverslips were washed twice with phosphate-buffered
saline (PBS) and ﬁxed and permeabilized with 70%
methanol at -20C overnight. Blocking of non-speciﬁc
binding of antibodies was performed by incubation of
cells in PBS buffer containing 1% BSA at room tem-
perature (RT) for 60 min. Incubations with primary and
secondary antibodies, diluted in PBS buffer, were per-
formed at 4C overnight and at RT for 60 min, respec-
tively. Cells were incubated with 20 lgm l
-1 propidium
iodide (Sigma-Aldrich Quimica, S.A., Madrid, Spain) or
with 1 lgm l
-1 40,6-diamidino-2-phenylindole (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) for 15 min at
RT to stain the nucleus. Between all steps, cells were
washed for 3 9 10 min with PBS at RT. Coverslips with
stained cells were mounted using Fluoromount G
(Southern Biotech, Hatﬁeld, PA, USA). Digital images
were obtained with a ﬂuorescent microscope (Olympus
BX51, Olympus, Melville, NY, USA) or by sequential
acquisition. Images were obtained by sequential acquisi-
tion with a confocal microscope (Olympus FV500,
Olympus, Melville, NY, USA).
Transmission electron microscopy
Treated and untreated A375 cells were harvested and
washed in 0.1 M phosphate buffer, pH 7.3, sedimented at
1,500 rpm, and immediately ﬁxed with 2.5% glutaralde-
hyde (Sigma-Aldrich Quimica, S.A., Madrid, Spain) in the
same buffer for 1 h. Subsequently, they were post-ﬁxed
with 1% OsO4 in cacodylate buffer, then alcohol-dehy-
drated and embedded in Epon as previously reported [21].
Thin sections were collected on nickel grids and stained
with uranyl acetate for observation under a Philips EM 208
electron microscope (Philips Electronic Instruments,
Eindhoven, Netherlands).
Flow cytometry
To measure intracellular ROS, treated and untreated cells
were loaded with 10 lM carboxi-H2DCFDA probe
(Molecular Probes; Europe BV, Leiden, The Netherlands)
during the last 30 min of treatment. Then, cells were har-
vested by trypsinization and washed twice with PBS before
being analyzed by ﬂow cytometry. Flow cytometric anal-
ysis was performed on at least 10,000 cells using a Coulter
Epics Elite ESP (EPICS Division Coulter Corp.), and
results were analyzed using the WinMDI 2.8 program.
Mitochondrial superoxide detection
MitoSOX
TM
Red mitochondrial superoxide indicator
(MolecularProbes,EuropeBV,Leiden,TheNetherlands)isa
ﬂuorogenic dye for highly selective detection of the super-
oxide in the mitochondria in living cells. MitoSOX
TM
Redreagentislive-cellpermeantandisrapidlyandselectively
targeted to the mitochondria. Once in the mitochondria,
MitoSOX
TM
Red reagent is oxidized by superoxide and
exhibits red ﬂuorescence. Cells were seeded into 96-well
microplatesatadensityof1 9 10
5cells ml
-1andallowedto
attachtothewellsovernight.Subsequently,cellsweretreated,
and controls without treatment were also included in each
experiment. Cells were loaded with 5 lM MitoSox and
incubatedfor10 minat37C,protectedfromlight.Then,cells
were washed with warm buffer and mitochondrial superox-
ide was measured using a ﬂuorimeter/microplate reader
(Fluoroskan Ascent, Labsystems) at excitation/emission of
approximately 510/580 nm.
Caspase activity assays
The activity of caspases-2, -4, -9, and -3 was measured
using commercially available Promokine colorimetric
assay kits (PromoCell GmbH, Heidelberg, Germany).
Brieﬂy, samples of untreated and treated cells were washed
with cold PBS and lysed on ice in 50 ll of cold lysis buffer.
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123Cell lysates were centrifuged at 10,0009g for 1 min to
precipitate cellular debris. The protein content of each
sample was quantiﬁed by means of the bicinchoninic acid
method. One hundred micrograms of protein extracts
were incubated with 100 ll of kit products, and assays
were performed in triplicate in 96-well plates on the
basis of the manufacturer’s protocol using a microplate
reader (ELx800, Bio-Tek Instruments, Winooski, VT) at
405 nm. Comparison of the absorbance from apoptotic
samples with that of an untreated control allowed deter-
mination of fold increase in caspase activity.
Superoxide dismutase (SOD) and catalase (CAT)
activity assays
The activity of SOD was measured using the Superoxide
Dismutase (SOD) Activity Assay Kit, from BioVision
(Mountain View, CA). This kit utilizes WST-1 that pro-
duces a water-soluble formazan dye upon reduction with
superoxide anion. The rate of the reduction with a super-
oxide anion is linearly related to the xanthine oxidase (XO)
activity, and is inhibited by SOD. Therefore, the inhibition
activity of SOD can be determined by a colorimetric
method. Samples of untreated and treated cells were lysed
in ice cold 0.1 M Tris/HCl, pH 7.4 containing 0.5% Triton
X-100, 5 mM b-ME, 0.1 mg/ml PMSF. Cell lysate was
centrifuged the crude tissue at 14,0009g for 5 min at 4C.
The supernatant contained total SOD activity from cyto-
solic and mitochondria. The assay was performed in trip-
licate using 96-well microplates, according to the
manufacturer’s instruction. The absorbance was read at
450 nm using a microplate reader (ELx800, Bio-Tek
Instruments, Winooski, VT) and the activity was calculated
as the inhibition rate of XO.
CAT was measured using the Catalase Activity Assay
Kit (BioVision). In the assay, catalase ﬁrst reacts with
H2O2 to produce water and oxygen. The unconverted H2O2
reacts with OxiRed
TM
, probe to produce a product, which
can be measured by a colorimetric method. Cell lysates
were centrifuged at 10,0009g for 15 min at 4C and the
supernatants were collected for the assay. The assay was
performed in triplicate using 96-well microplates, accord-
ing to the manufacturer’s instruction. The absorbance was
read at 570 nm using a microplate reader (ELx800,
Bio-Tek Instruments, Winooski, VT) and the activity was
calculated in nmol/min/ml.
SDS–polyacrylamide gel electrophoresis
and immunoblotting
Treated and untreated melanoma cells were harvested by
trypsinization. Washed in cold PBS and lysed in RIPA
lysis buffer (80 mM Tris HCl pH 8, 150 mM NaCl, 1%
NP 40, 0.5% sodium deoxycholate, 0.1% SDS) containing
Protease Inhibitor Cocktail (Sigma-Aldrich Quimica, S.A.,
Madrid, Spain) for 15 min on ice. Lysates were then
cleared by centrifugation at 10,000 g, for 5 min. Total
protein concentration was determined using the bicinch-
oninic acid assay. Equal amounts of total proteins from
each sample were resolved by electrophoresis on an SDS–
polyacrylamide gel and then transferred onto a nitrocel-
lulose membrane (Whatman GmbH, Dassel, Germany).
The blots were blocked with PBS containing 5% non-fat
milk and 0.1% Tween-20 for 1 h and then probed over-
night with an appropriate dilution of the primary anti-
body. After washing, membranes were incubated for 1 h
with horseradish peroxidase-linked secondary antibody.
Finally, proteins were visualized by enhanced chemilu-
minescence using the SuperSignal
 West Pico Chemilu-
minescent Substrate (Thermo Scientiﬁc, Rockford, IL,
USA).
Transfection of Atg7 small interference RNA (siRNA)
A375 and HT144 melanoma cells were transfected by
means of the SignalSilence Atg7 siRNA I (Cell Signalling
Technology, Inc., Danvers, MA, USA) using Lipofect-
amine RNAiMAX (Invitrogen, Carlsbad, CA, USA) as
transfection agent, according to the manufacturer’s
instructions. The Fluorescein Conjugate SignalSilence
Control siRNA (Cell Signalling Technology, Inc., Danvers,
MA, USA) was used for optimization experiments,
assessment of transfection efﬁciency and as a negative
siRNA control.
Cells (10
4) were seeded in 96-well microplates and then
100 nM Atg7 siRNA per well were mixed with Lipofect-
amine RNAiMAX agent in OPTI-MEM I medium (Invit-
rogen, Carlsbad, CA, USA) and added to the cells.
Seventy-two hours after transfection, cell lysates were
obtained to verify the Atg7 protein knockdown by Western
Blotting using an Atg7 monoclonal antibody. In parallel
experiments, 48 h after transfection, cells were treated with
10 lM TEF for several hours and cell viability was
determined by XTT assay. Four separate experiments were
performed and the gene knockdown was higher than 70%
with less than 5% of cell death.
Statistical analysis
The level of statistical signiﬁcance between sample means
was determined using the Student t-test; P\0.05 was
considered to be statistically signiﬁcant, and P\0.01 was
considered to be statistically very signiﬁcant.
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123Results
Terfenadine induces distinct apoptotic pathways
in A375 human melanoma cells
We began by studying the ability of TEF to induce apop-
tosis in various melanoma cell lines treated in complete
medium (containing 10% FCS). We assessed the effect of
different concentrations of TEF using the XTT assay
(Fig. 1a) and we saw that the cytotoxic effect of TEF was
dose-dependent in all tested cell lines. The half maximal
inhibitory concentration value (IC50) after 24 h of TEF
treatment in complete medium was 10.4 lM for A375
cells, 9.9 lM for Hs294T cells and 9.6 for HT144 cells.
Then, we analyzed the effect of TEF treatment on A375
cells in medium deprived of serum (Fig. 1b). In this case,
the effect of TEF was also dose-dependent. The IC50 after
8 h of TEF treatment in the absence of serum was 6.8 lM
for A375 cells. These results indicate that TEF induces
dose-dependent cytotoxicity in both culture conditions.
As shown in Fig. 1c, the cytotoxic effect of TEF was
time-dependent either in serum-free or in complete med-
ium. Moreover, starvation (SS) enhanced the cytotoxic
effect of TEF. While 10 lM TEF/SS required only about
8 h to induce practically total cell death, 10 lM TEF
required about 32–40 h to induce the same level of cyto-
toxicity. We studied the expression of cleaved caspase-3
by ﬂuorescence microscopy, and we found that 10 lM
TEF/SS and 10 lM TEF treatment for 6 and 24 h, respec-
tively, induced caspase-3 activation and morphological
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Fig. 1 Dose and time-
dependent apoptosis induced by
TEF on A375 melanoma cells in
different culture conditions.
a The dose-dependent effect of
TEF on A375, HT144 and
Hs294T cells. Cells were treated
with different concentrations of
TEF in complete medium
(supplemented with 10% FCS)
and cell viability was assessed
by means of an XTT viability
assay after the indicated times.
b The dose-dependent effect of
TEF/SS on A375 cells. Cells
were treated with different
concentrations of TEF in serum
starvation (SS) conditions and
cell viability was assessed by
means of an XTT viability assay
after the indicated times. c The
time-dependent effect of TEF
on A375 cells. Cells were
treated with 10 lM TEF in
complete medium or in absence
of FCS for the indicated times,
and cell viability was assessed
by means of an XTT viability
assay. d Activated caspase-3
detection. Control cells, cells
treated with 10 lM TEF/SS for
6 h and cells treated with
10 lM TEF for 24 h were
stained for cleaved caspase-3
(red). Then, cell nuclei (blue)
were counterstained with
40,6-diamidino-2-phenylindole
for 10 min, and the cells were
analyzed under a ﬂuorescence
microscope. Bar 10 lm
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123nuclear changes that are characteristic of apoptosis (Fig. 1d),
indicating that TEF induces cell death by apoptosis in
human melanoma cells either in complete medium or in
medium deprived of serum.
To study if SS was involved in the molecular mecha-
nisms of apoptosis induced by TEF, a time-course analysis
of activation of the initiator caspases-2, -4, and -9 and the
executioner caspase-3 was performed in melanoma cells
treated with TEF (Fig. 2). We found that TEF/SS activated
caspases-2, -4, and -3 after 2 and 3 h of treatment, but there
was no signiﬁcant activation of caspase-9 at that time
point. The activation of caspase-9 was observed only after
4 h of treatment, when the activity of caspases-2, -4, and -3
had increased dramatically (Fig. 2a). These results indicate
that caspase-9 is activated downstream of caspase-3.
In contrast, the addition of TEF in complete medium
was found to activate all of the initiator caspases-2, -4,
and -9 after 8 h of treatment. The activation levels of the
studied caspases reached a maximal level at 28 h (Fig. 2b).
These results suggest that TEF activates three distinct
apoptotic pathways. To conﬁrm the role of initiator casp-
ases in TEF-induced apoptosis, we pre-treated A375 cells
with speciﬁc inhibitors for each caspase (-2, -4, and -9)
before the addition of TEF. We found that each speciﬁc
caspase inhibitor partially blocked the effect of TEF at 28 h
of treatment (Fig. 2c).
Terfenadine induces ROS generation
To test if TEF treatment could lead to ROS generation, we
measured intracellular ROS levels by ﬂow cytometry after
labeling cells with carboxi-H2DCFDA, a speciﬁc ROS-
detecting ﬂuorescent dye. We began by investigating the
effect of SS on ROS generation and observed that the
absence of serum in culture medium for 4 h was enough to
produce a signiﬁcant increase in ROS levels. Moreover, we
found that TEF/SS also produced a low increase in ROS
levels after 4 h of treatment, compared to control cells
cultured in serum-free medium for 4 h (Fig. 3a). We fur-
ther analyzed ROS generation by TEF in complete medium
and found a signiﬁcant increase of ROS levels at 30 min.
Then, ROS generation decreased to control levels at 8 h,
but an important increase followed at 16 h and reached a
maximal level at 28 h of treatment (Fig. 3b). Taken toge-
ther, these results indicate that TEF induces an intracellular
ROS increase. In addition, pre-treatment with BAPTA-
AM, a calcium chelator, prevented ROS production
(Fig. 3c), indicating that the observed rise of ROS gener-
ation is dependent on intracellular calcium concentration
increase. Moreover, we observed a mitochondrial super-
oxide increase after TEF treatment using MitoSox, a
mitochondrial superoxide indicator (Fig. 3d). Overall,
these results indicate that TEF treatment induces
mitochondrial and cytosolic ROS levels increase. Further-
more, pre-treatment with the antioxidant a-tocopherol
(vitamin E) for 1 h before the addition of TEF effectively
blocked ROS induction in TEF-treated cells, either in
serum-free medium or in complete medium (Fig. 3e).
In order to investigate the role of the endogenous anti-
oxidant defense system in TEF treatment, we studied the
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123activation of SOD and CAT, which are in charge of the
superoxide and hydrogen peroxide remove, respectively
[14]. We saw that TEF did not induce SOD activity.
Indeed, SOD activity decreased at the time of 8 and 24 h of
treatment (Fig. 4a). However, CAT activity was notably
increased at 30 min and later on at 8 and 24 h (Fig. 4b).
These results indicate that the observed ROS levels
increase is not due to a failure in the antioxidant defense
system.
Involvement of ROS generation in terfenadine-induced
DNA damage and apoptosis
To analyze the role of ROS in TEF-induced apoptosis, we
assessed cell viability of TEF-treated A375 cells in the
presence of vitamin E. Vitamin E did not protect cells from
cytotoxicity induced by TEF/SS, but it almost completely
blocked the cytotoxic effect of TEF in cells treated in
complete medium (Fig. 5a). The histone H2A.X becomes
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Fig. 3 TEF induces ROS production in A375 melanoma cells. Flow
cytometry analysis of intracellular ROS using a carboxi-H2DCFDA
probe. A375 cells were treated with 10 lM TEF in the absence (a)o r
in the presence (b) of FCS for the indicated periods of time. ROS
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in complete medium. c ROS induction by TEF is prevented by
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were treated with 10 lM TEF for the indicated periods of time.
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e ROS induction by TEF is blocked by vitamin E (vit E). A375
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Control cells were cultured in complete medium. Data represent mean
values ± SD of three determinations from three separate experi-
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123phosphorylated in response to DNA double-strand breaks,
and we further studied the effect of ROS on DNA damage
by analyzing phosphorylated H2A.X expression by Wes-
tern blot. We found that both TEF/SS and TEF induced a
signiﬁcant increase of phosphorylated H2A.X. In addition,
inhibition of ROS with vitamin E signiﬁcantly reduced
phosphorilated H2A.X in A375 cells treated with TEF in
complete medium but not in cells treated with TEF/SS
(Fig. 5b). These results indicate that oxidative stress is an
upstream effector of terfenadine-induced DNA damage and
apoptosis under normal conditions but not in cells treated
in serum-free medium. Moreover, vitamin E prevented
citotoxicity (Fig. 5c), caspase-3 cleavage and phosphory-
lated H2A.X expression (Fig. 5d) in HT144 melanoma
cells treated with TEF in complete medium.
Involvement of ROS generation in the p53/p73 pathway
induced by terfenadine
p53/p73 pathway were analyzed by Western Blot and we
found that p53, p73 and p21 levels decreased in TEF/SS
treated A375 cells but no alteration of Noxa levels was
observed (Fig. 6a). Conversely, an increase of p53, p73,
p21 and Noxa protein levels was observed in cells treated
with TEF in complete medium (Fig. 6c), suggesting that
under these conditions, the p53/p73 pathway could be
involved inn TEF-induced apoptosis.
We further analyzed the effect of ROS in p53/p73
pathway activation. As expected, the presence of vitamin E
did not alter the expression of tested proteins in TEF/SS-
treated cells (Fig. 6b). However, when A375 cultures were
treated in complete medium, vitamin E signiﬁcantly
reduced TEF-induced p73 accumulation and Noxa
expression but did not block p53 and p21 induction
(Fig. 6d). Similar results were obtained with HT144 cells
treated with TEF in complete medium, in the absence or
presence of Vit E (Fig. 6e).
p73 localization assay by confocal microscopy demon-
strated that 16 h of TEF treatment induced p73
translocation from cytoplasm to the nucleus in A375 cells
(Fig. 7a), which reﬂects its activation. Moreover, vitamin E
partially prevents this translocation, indicating ROS
dependence. We also studied cytochrome c localization by
confocal microscopy. As shown in Fig. 7b, TEF treatment
for 16 h induced cytochrome c release from mitochondria
to cytosol, as is reﬂected by the transition from a punctate
distribution in the cytoplasm in control cells to diffuse
localization in the cytoplasm in treated cells. Vitamin E
also partially prevented cytochrome c release from the
mitochondria to the cytosol. Overall, these results indicate
that p73 and Noxa induction by TEF—but not p53 and p21
induction—depend on ROS generation and that the mito-
chondrial apoptotic pathway is involved in TEF-induced
apoptosis.
Terfenadine induces p53-independent citotoxicity
Since vitamin E prevents cytotoxicity induced by TEF, but
not p53 expression increase, we assessed the effect of
cyclic piﬁthrin-alpha (PFT-a), a pharmacological inhibitor
of p53 transcriptional activity, on cell viability of cells
treated with TEF during 24 h in complete medium. We
found that PFT-a did not prevent the cytotoxic effect of
TEF either in A375 (Fig. 8a) or in HT144 (Fig. 8b). These
results indicate that TEF induces apoptosis independently
of p53 transcriptional activity in melanoma cells.
Terfenadine induces autophagy by ROS-dependent
and -independent mechanisms
Because reticular stress and ROS production have been
linked with autophagy, we investigated autophagy induc-
tion by TEF treatment. Electron microscopy examination
of cells treated with TEF for 8 h revealed a massive vac-
uolization of the cytoplasm (Fig. 9a). Autophagic vacuoles
of both double and multiple membranes (Fig. 9b) and at
various stages (Fig. 9c) can be observed. Moreover, Wes-
tern blot analysis revealed that both TEF and TEF/SS could
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123rapidly elicit accumulation of LC3B-II, a lipidated form of
LC3B, which is localized on the autophagic vacuoles
(Fig. 10a). Indeed, confocal microscopic analysis indicated
formation of the LC3B punctate appearance in cells treated
with TEF for 8 h and with TEF/SS for 4 h, which would
represent the autophagic vacuoles (Fig. 10b).
We next examined how ROS production could affect
autophagy triggered by TEF and found that vitamin E did
not block LC3B-II accumulation induced by TEF/SS but
strongly inhibited LC3B-I to LC3B-II conversion when
cells were treated in the presence of serum (Fig. 10c).
These results indicate that autophagy induced by TEF can
be independent or dependent of ROS generation.
Finally, we down-regulated Atg 7 by means of siRNA
transfection to investigate how autophagy inhibition could
affect TEF-induced cell death. Transfection optimization
was performed using a ﬂuorescein conjugate control
siRNA, that doesn’t lead to the speciﬁc degradation of any
cellular message and also serves as a negative control.
Figure 11a shows the high efﬁciency of transfection:
Fluorescent cells have incorporated the ﬂuorescein
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123conjugate control siRNA. Using the same culture condi-
tions, Atg7 siRNA was transfected to the cells and 72 h
after transfection cell lysates were obtained to verify the
Atg7 protein knockdown by Western Blotting (Fig. 11b).
The viability experiments were performed by XTT assay
after 48 h of transfection. As can be seen in Fig. 11c, Atg 7
down-regulation partially prevented cell death induced by
TEF at initial times of treatment in both A375 and HT144
cells but not when TEF had ﬁnally killed most of the cells.
These results indicate that autophagy acts by promoting
cell death in TEF-treated melanoma cells.
Discussion
Most of the currently available anticancer drugs are often
non-selective antiproliferative agents that preferentially kill
dividing cells [22]. Thus, the search for new anticancer
agents or therapeutic strategies without these side effects is
pressing. In this context, we previously demonstrated that
TEF induces dose-dependent apoptosis in a variety of
human melanoma cell lines but not in normal melanocytes
[2]. Depletion of ER Ca
2? stores and Ca
2? inﬂux from the
extracellular medium mediate TEF-induced apoptosis [3].
Control
TEF (16 h)
Vit E + TEF (16 h)
e g r e m 3 7 p I P A D a
b
Control TEF (16 h) Vit E + TEF (16 h) 
Fig. 7 Terfenadine induces
ROS-dependent p73 nuclear
translocation and cytochrome
c release. a p73 localization
analysis. A375 control cells and
10 lM TEF-treated cells for
16 h, either in the presence or in
the absence of 100 lM vitamin
E( vit E) were labeled for p73
(green), and then nuclei were
counterstained with 40,6-
diamidino-2-phenylindole
(blue). b Cytochrome
c localization analysis. Control
and 10 lM TEF-treated cells for
16 h, either in the presence or in
the absence of 100 lM vit E
were labeled for cytochrome
c (green), and then cells were
incubated with 40,6-diamidino-
2-phenylindole to stain the
nucleus (blue). The cells were
viewed and analyzed with a
confocal microscope. Bars
10 lm
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123In the present work, we have shown that TEF can activate
distinct apoptotic signaling pathways and that SS increases
TEF-induced cytotoxicity in A375 human melanoma cells.
Importantly, we have also observed that both TEF treat-
ment and SS induce ROS generation; however, only the
apoptosis induced by TEF in the presence of serum was
ROS-dependent. TEF treatment in serum-free medium
induced ROS-independent apoptosis because the inhibition
of ROS production by vitamin E did not protect against the
apoptosis. RE seems to form a largely interconnected
tubular network that is in close contact with the mito-
chondria. Upon ER Ca
2? depletion, the mitochondrial
surface, which is situated in close proximity to the ER, is
exposed to high concentration of calcium. High concen-
trations of Ca
2? appear to have several negative effects on
mitochondrial function. At the heart of understanding how
Ca
2? can be both a physiological and a pathological
effector of mitochondrial function is the issue of how Ca
2?
modulates mitochondrial ROS generation. The majority of
ROS are products of mitochondrial respiration. Stimulation
of the respiratory chain activity by Ca
2? would enhance
ROS output by making the whole mitochondrion work
faster and consume more O2. Indeed, mitochondrial ROS
generation correlates well with metabolic rate [23]. Here
we have demonstrated that ROS induction by TEF is
dependent on intracellular calcium concentration increase
and that there is a production of ROS into the mitochondria
in response to TEF treatment.
Other authors have also described that starvation pro-
vided protection to normal cells, but not to a variety of
a
b
40
60
80
100
120
NS
0
20
40
60
80
100
120
NS
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
0
20
40
PFT-α PFT-α
+TEF
TEF
PFT-α PFT-α
+TEF
TEF
Fig. 8 Effect of p53 inhibition on cell death induced by TEF. A375
(a) and HT144 melanoma cells (b) were incubated with 30 lM
piﬁthrin-alpha (PFT-a) during 1 h before 10 lM TEF addition for
28 h in complete medium. Then, cell viability was assessed using the
XTT viability assay. Data represent mean ± SD of three determina-
tions from three separate experiments.
NSP values[0.5
Fig. 9 Terfenadine induces ultrastructural features of autophagy.
A375 cells were treated with 10 lM TEF for 8 h and processed for
electron microscopy. a The induction of autophagy is manifested by
massive vacuolization of the cytoplasm. Arrows indicate autophagic
vacuoles different in size. b Note the double membrane or the
multimembrane structure of the autophagic vacuoles. c In the same
cell, immature autophagic vacuoles characterized by an electron
density equivalent to the cytoplasm coexist with late vesicles, in
which catabolic processes have been already started (characterized by
an increased electron density). Bars 1 lm
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123cancer cells treated with chemotherapy drugs that are
implicated in the generation of ROS and DNA damage
[23]. In addition, some results show that although most
tumor cells exhibit an antioxidant phenotype, human mel-
anoma cells have depressed antioxidant capacity compared
to normal melanocytes [24]. We have seen that the mito-
chondrial antioxidant enzyme SOD was not activated by
TEF, but CAT was activated in response to TEF treatment,
indicating that the antioxidant system is not completely
depressed. Our observation that caspase-4 was activated by
TEF was not surprising because caspase-4 is activated upon
ER Ca
2? release [10]. This result was validated by inhi-
bition of caspase-4 activity. In addition, we have also
shown that TEF can potentially activate distinct intrinsic
apoptotic signaling pathways that are summarized in
Fig. 11. The relevance of these signaling pathways and the
precise mechanism of activation appear to differ depending
on the intensity of the death stimulus or the presence of
survival factors in the medium of TEF treatment.
A severe apoptotic stimulus produced by TEF in med-
ium deprived of serum quickly leads to Ca
2?-dependent
DNA damage and activation of caspase-2 as the predomi-
nant mechanism of apoptosis induction, involving the
mitochondrial apoptotic pathway [2, 3]. Caspase-2, which
is activated by an autoproteolytic mechanism in response to
DNA damage, can directly interact with the mitochondria
and trigger mitochondrial membrane permeabilization and
cytochrome c release [25, 26]. In this case, we have seen
that caspase-9 is activated downstream of caspase-2 and -4.
The mechanism of caspase-9 activation can result from
cytochrome c release. Another possibility is that caspase-9
becomes activated by caspase-4 activity because it has
been shown that, following its activation at the ER, cas-
pase-4 can directly cleave pro-caspase-9 in a mitochon-
drial-independent manner [27, 28].
p53/p73 pathway induction in cells treated with TEF in
medium deprived of serum was studied. We observed a
decrease in p53, p73 and p21 and no change in Noxa
protein levels, indicating that the p53/p73 pathway is not
involved in the activation of the mitochondrial apoptotic
pathway. A decrease in p53, p73 and p21 protein levels can
result from the failure of proper protein folding caused by
disruption of ER Ca
2? homeostasis [29]. We have also
demonstrated that although ROS levels increase, the high
intensity of the ER Ca
2? release seems sufﬁcient to acti-
vate distinct apoptotic pathways without the contribution of
ROS as an apoptotic signaling ampliﬁcation mechanism.
By contrast, treatment with TEF in complete culture
medium triggers ROS-mediated apoptosis and DNA dam-
age. This treatment induces a lower intensity of Ca
2?
release that requires ROS production by mitochondria to
enhance the apoptotic stimulus. In this cellular context, we
have observed a simultaneous activation of caspases-2, -4,
and -9, suggesting activation of at least three distinct
apoptotic mechanisms. We also found an accumulation of
p53, p73, p21, and Noxa. These results indicate that the
a
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Fig. 10 ROS involvement in
TEF-induced autophagy.
a Western blot analysis of
LC3B normalized with actin.
50 lg of total cell extracts were
loaded per lane. Cells were
treated with 10 lM TEF or with
10 lM TEF/SS for the indicated
times. b LC3B localization
analysis. Control cells cultured
in complete medium and cells
treated with 10 lM TEF for 8 h
were stained for LC3B (red),
and then cells were incubated
with 40,6-diamidino-2-
phenylindole to stain the nuclei
(blue). The cells were viewed
and analyzed with a confocal
microscope. Bar 10 lm.
c Western blot analysis of LC3B
normalized with actin. 50 lgo f
total cell extracts were loaded
per lane. Cells were treated with
10 lM TEF or with 10 lM
TEF/SS in the presence of
100 lM vitamin E (vit E) for the
indicated times
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123p53/p73 pathway can contribute to mitochondrial mem-
brane permeabilization induction, cytochrome c release,
and caspase-9 activation. Intriguingly, ROS inhibition by
vitamin E partially prevented p73 and Noxa expression but
not p53 and p21 induction, suggesting that Noxa expres-
sion and apoptosis are regulated independently of p53.
Recently, other authors have described the role of Noxa in
p53-independent apoptosis in melanoma cells [30–32]. On
the other hand, overexpression of E2F1, which stimulates
transcription of the p73 gene, has been shown to induce
apoptosis in melanoma cells [33] and sensitize melanoma
cells to apoptosis [34]. Moreover, Tuve and colleagues
have demonstrated that a transcriptionally active form of
p73 (TA-p73b) increases chemosensitivity of human
malignant melanomas to the standard therapeutic agents
adriamycin and cisplatin [35]. Importantly, we have shown
that TEF induces p73 accumulation, p73 nuclear translo-
cation, and Noxa expression, apparently in a p53-inde-
pendent manner. We have hypothesized that p73 might
have a role in Noxa induction and apoptosis. Taken toge-
ther, these results suggest that agents such as TEF that
induce the expression of p73 and Noxa might be clinically
useful in the treatment of melanoma.
Finally, we have shown that TEF induces autophagy by
electron microscopy, LC3 dot formation, and LC3 con-
version from LC3-I to LC3-II. Again, the intensity of the
death stimulus determines the mechanism responsible for
autophagy activation. We observed that a severe apoptotic
stimulus induced autophagy independently of ROS gener-
ation, whereas autophagy induced by a more moderate
stimulus was dependent on ROS production. In the pres-
ence of an apoptotic stimulus, autophagy has been descri-
bed as both an alternative route to cell death and an
adaptation mechanism to environmental stress. In order to
investigate the role of autophagy in cell death induced by
TEF, we down-regulated the Atg 7 protein to block the
autophagic process. The molecular machinery of autoph-
agy was largely discovered in yeast and referred to as
autophagy-related (Atg) genes. Formation of the auto-
phagosome involves an ubiquitin-like conjugation system
in which Atg12 is covalently bound to Atg5 and targeted to
autophagosome vesicles. This conjugation reaction is
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Fig. 11 Effect of Atg 7 downregulation in TEF-induced cytotoxicity.
a Assessment of transfection efﬁciency using SignalSilence Control
siRNA (Fluorescein Conjugate), that also serves as a negative control.
Cells were viewed under a confocal microscope. b Down-regulation
of Atg 7 protein following transfection with speciﬁc Atg 7 siRNA.
50 lg of total cell extracts of transfected and non transfected cells
were loaded per lane, separated by electrophoresis and analyzed by
immunoblotting. c Atg 7 down-regulation partially prevented TEF-
induced cytotoxicity. Cell viability was determined after 48 h of
siRNA transfection. *P values\0.05
Fig. 12 Schematic representation of the signaling apoptotic pathways
induced by TEF. TEF rapidly induces ER calcium release through
PLC-IP3 pathway [3], leading to caspase-4 activation and to
intracellular calcium increase. Accumulation of calcium in the
nucleus (N) causes DNA damage; and in the mitochondria (M)i t
induces ROS production. An increase of ROS levels can cause DNA
damage in the nucleus and cytochrome c release from mitochondria,
leading to caspase-9 activation. Caspase-9 can also be directly
activated by caspase-4. Caspase-2 and the p53/p73 signaling pathway
become activated in response to DNA damage. Caspase-2 can directly
cause cytochrome c release from mitochondria. p53 can induce cell
cycle arrest through p21 induction and p73 could be responsible of
Noxa induction and subsequent cytochrome c release and caspase-9
activation. The initiator caspases-2, -4 and -9 cause executioner
caspases activation and apoptosis
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123mediated by the ubiquitin-E1-like enzyme Atg7 and the
E2-like enzyme Atg10 [17–20]. Our results demonstrate
that the inhibition of the autophagic protein Atg 7 leads to a
decreased cell death rate in TEF-treated melanoma cells,
indicating that autophagy acts by promoting death mech-
anism in cells challenged with TEF. However, whether
autophagy induction in dying cells actually causes death, or
whether it simply occurs as a process alongside it, remains
controversial. It is becoming clear that apoptosis induction
is often associated with increased autophagy and that they
are interconnected, but the reciprocal inﬂuence of the two
pathways has not been completely understood [36].
In summary, this study shows the great potential of TEF
to kill A375 human melanoma cells in different culture
conditions through distinct apoptotic pathways that emerge
from Ca
2? homeostasis disruption (summarized in
Fig. 12). Serum withdrawal enhances the intensity of the
death stimulus induced by TEF. Caspase-4, which becomes
activated upon ER stress, and caspase-2, activated in
response to DNA damage, are the predominant apoptotic
mechanisms. By contrast, TEF treatment in complete
medium induces apoptosis through ROS generation,
involving caspase-4, caspase-2, caspase-9, p73, and Noxa
induction. Moreover, autophagy also promotes cell death
under these culture conditions. Based on these results, we
suggest that TEF alone or in combination with other
antineoplasics could deﬁne a new therapeutic strategy for
melanoma. Further in vivo studies could provide evidence
regarding the antitumoral potential of this drug.
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